关键数据
3.310今开
3.370最高
87.44K成交量
15.97市盈率 TTM
968.98市盈率动
--股息TTM
0.06%换手率
3.310昨收
3.220最低
290.32K成交额
11.42市盈率静
2.29市净率
0.00%股息率 TTM
10.60%ROA
7.66052周最高
0.04量比
42.42M净利润
145.93M总股本
0.2078每股收益TTM
1.47Beta
13.77%ROE
3.03052周最低
4.99%振幅
79.33%毛利率
484.49M总市值
-0.56回报/风险
2.72%风险率

即将为您带来更多新闻,敬请期待。。。
MiMedx Group Inc评分
0.18与上次评分对比预测8.00
财务诊断7.75
技术分析5.89
公司估值8.63
机构认同度7.00
风险评估6.05
分析师评级
MiMedx Group Inc 最新财报电话会记录
MiMedx (MDXG) 2026年第三季度业绩电话会议:外科业务增长及更新后的业绩指引
MiMedx 2026年第三季度财报电话会议:手术业务销售额增长9%,创伤护理业务下降71%,调整后EBITDA实现转正,并更新了2026年销售指引。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
MiMedx Group Inc 简介
MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
行业生物技术与医疗研究
公司代码MDXG
员工数量837
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| EW Healthcare Partners | 18.93% |
|---|
| BlackRock Institutional Trust Company, N.A. | 5.90% |
|---|
| Trigran Investments, Inc. | 4.14% |
|---|
| Vanguard Capital Management, LLC | 3.47% |
|---|
| 股东类型 | 占比 |
|---|
| Investment Advisor | 20.19% |
|---|
| Investment Advisor/Hedge Fund | 19.89% |
|---|
| Venture Capital | 18.93% |
|---|
| Hedge Fund | 11.86% |
|---|
常见问题
MiMedx Group Inc(MDXG)的当前股价是多少?
MiMedx Group Inc(MDXG)的当前股价是 3.32。
MiMedx Group Inc的股票代码是什么?
MiMedx Group Inc的股票代码是MDXG。
MiMedx Group Inc股票的52周最高点是多少?
MiMedx Group Inc股票的52周最高点是7.77。
MiMedx Group Inc股票的52周最低点是多少?
MiMedx Group Inc股票的52周最低点是3.03。
MiMedx Group Inc的市值是484.49M。
现在MiMedx Group Inc(MDXG)的股票是买入、持有还是卖出?
根据分析师评级,MiMedx Group Inc(MDXG)的总体评级为买入,目标价格为7.00。
MiMedx Group Inc(MDXG)股票的每股收益(EPS TTM)是多少
MiMedx Group Inc(MDXG)股票的每股收益(EPS TTM)是0.21。